Topical bromfenac for prevention and treatment of cystoid macular edema following cataract surgery: a review
John D Sheppard1,2 1Virginia Eye Consultants, 2Department of Ophthalmology, Eastern Virginia Medical School, Norfolk, VA, US Abstract: Topical nonsteroidal anti-inflammatory drugs (NSAIDs) and corticosteroids, alone or in combination, have historically been used off label in the US to prevent and...
Guardado en:
Autor principal: | Sheppard JD |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5bc260cfa78e4aaead5935d2ffd2a3dd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Bromfenac 0.09% bioavailability in aqueous humor, prophylactic effect on cystoid macular edema, and clinical signs of ocular inflammation after phacoemulsification in a Mexican population
por: Palacio C, et al.
Publicado: (2016) -
Topical NSAIDs, intravitreal dexamethasone and peribulbar triamcinolone for pseudophakic macular edema
por: Javier Obis, et al.
Publicado: (2021) -
Pseudophakic cystoid macular edema: update 2016
por: Grzybowski A, et al.
Publicado: (2016) -
A randomized double-masked study to compare the ocular safety, tolerability, and efficacy of bromfenac 0.075% compared with vehicle in cataract surgery subjects
por: Hosseini K, et al.
Publicado: (2016) -
Treatment costs of cystoid macular edema among patients following cataract surgery
por: Schmier JK, et al.
Publicado: (2016)